About us
Profile
Contributors
Staff
Address
Contact Us
Articles
Canada
USA
International
Topics
Access to Medicines
Innovation
Comparative Effectiveness
Health Technology Assessment
Importation
Global Public Health
Emerging Markets
Patient Safety
Patient Advocacy
Events
Publications
Presentations
Reports and Research Papers
Register
Home
health spending
1.
Pharmacy reform in Ontario to address overpriced generic medicines
2.
Underlying chronic conditions significantly increase hospital spending in Canada
3.
Chronic disease self management programs improve health and reduce overall health care costs
4.
Last year, prescription drugs were the smallest component of government health care spending growth in Canada
5.
Impacts of Liability on the Affordability of Healthcare
6.
Consumers in Canada spend the same percentage of their income on prescription drugs as consumers in the United States
7.
Canada’s National Pharmaceutical Strategy: Improving access to medicines or containing costs by limiting patient/physician treatment choices?
8.
Growing numbers of employers use care management strategies to combat chronic disease risk factors and contain health benefit costs
9.
Focusing on improving health outcomes instead of decreasing access to testing and treatments will do more to contain health spending growth
10.
Despite misleading claims that drugs accounted for most of Canadian health care spending growth, institutional care continues to drive Canadian health spending
<<
Start
<
Prev
1
2
3
4
Next
>
End
>>
Powered by
Tags for Joomla
Top Topics
access to medicines
canada
chronic disease
disease management
global health
health policy
health spending
importation
innovation
usa
Latest News
Canada is slow to adopt innovative medicines, according to new study
Global partnerships working to eradicate malaria - World Malaria Day 2010
Pharmacy reform in Ontario to address overpriced generic medicines
Counterfeit medicines threaten public health in Peru
Summary Report: Benefit-Risk Roundtable
Popular Articles
Global partnerships facilitate access to medicines
Treatment of rare disorders: U.S and Europe enact legislation to encourage innovation and access while Canada lags behind
Case studies for global health
Accessing Drugs for Rare Diseases in Canada: The Patient Perspective
2008 UNAIDS report highlights decrease in global rate of infections; role of life-saving drugs
Social Media
Login
Username:
Password:
Remember Me
Forgot your password?
Forgot your username?
Create an account
Who's Online
We have
85 guests
online
Latest Events
No events
copyright © World Health Advocacy Inc.
